Middle East Healthcare Co.’s (Saudi German Health) net profit surged to SAR 180.2 million for 2023, compared to SAR 75.2 million a year earlier.
Item | 2022 | 2023 | Change |
---|---|---|---|
Revenues | 2,151.74 | 2,653.17 | 23.3 % |
Gross Income | 680.01 | 1,014.41 | 49.2 % |
Operating Income | 140.34 | 342.50 | 144.0 % |
Net Income | 75.18 | 180.18 | 139.7 % |
Average Shares | 92.04 | 92.04 | - |
EPS (Riyals) | 0.82 | 1.96 | 139.7 % |
This was fueled by higher revenue due to an increase in number of inpatients as well as the group’s capacity, in addition to higher efficiency on ramping up of new facilities.
Item | Q4 2022 | Q4 2023 | Change |
---|---|---|---|
Revenues | 617.96 | 719.81 | 16.5 % |
Gross Income | 204.01 | 293.96 | 44.1 % |
Operating Income | 57.96 | 87.15 | 50.4 % |
Net Income | 33.16 | 36.50 | 10.1 % |
Average Shares | 92.04 | 92.04 | - |
EPS (Riyals) | 0.36 | 0.40 | 10.1 % |
Item | Q3 2023 | Q4 2023 | Change |
---|---|---|---|
Revenues | 671.05 | 719.81 | 7.3 % |
Gross Income | 266.33 | 293.96 | 10.4 % |
Operating Income | 109.85 | 87.15 | (20.7 %) |
Net Income | 53.30 | 36.50 | (31.5 %) |
Average Shares | 92.04 | 92.04 | - |
EPS (Riyals) | 0.58 | 0.40 | (31.5 %) |
Q4 2023 net profit increased 10% year-on-year (YoY) to SAR 36.5 million from SAR 33.16 million.
On a quarterly basis, net earnings dropped 31.5% from SAR 53.30 million in Q3 2023.
Total shareholders’ equity, after minority interest, stood at SAR 1.51 billion by Dec. 31, 2023, compared to SAR 1.36 billion a year ago.
Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
---|---|---|---|---|---|---|---|
Q1 2014 | 359.18 | - | 199.49 | - | 80.16 | - | 0.87 |
Q2 2014 | 347.08 | - | 185.78 | - | 92.80 | - | 1.01 |
Q3 2014 | 323.16 | - | 174.49 | - | 74.36 | - | 0.81 |
Q4 2014 | 369.34 | - | 190.01 | - | 84.64 | - | 0.92 |
2014 | 1,398.75 | 68.9 % | 749.76 | 74.2 % | 331.97 | 142.0 % | 3.61 |
Q1 2015 | 391.64 | 9.0 % | 208.99 | 4.8 % | 105.39 | 31.5 % | 1.15 |
Q2 2015 | 372.00 | 7.2 % | 203.88 | 9.7 % | 91.79 | (1.1 %) | 1.00 |
Q3 2015 | 352.20 | 9.0 % | 183.23 | 5.0 % | 90.75 | 22.0 % | 0.99 |
Q4 2015 | 418.69 | 13.4 % | 214.04 | 12.6 % | 102.32 | 20.9 % | 1.11 |
2015 | 1,534.53 | 9.7 % | 810.13 | 8.1 % | 390.25 | 17.6 % | 4.24 |
Q1 2016 | 421.52 | 7.6 % | 216.62 | 3.7 % | 104.20 | (1.1 %) | 1.13 |
Q2 2016 | 410.07 | 10.2 % | 212.49 | 4.2 % | 74.07 | (19.3 %) | 0.80 |
Q3 2016 | 379.09 | 7.6 % | 199.40 | 8.8 % | 99.64 | 9.8 % | 1.08 |
Q4 2016 | 404.96 | (3.3 %) | 199.88 | (6.6 %) | 84.73 | (17.2 %) | 0.92 |
2016 | 1,615.64 | 5.3 % | 828.39 | 2.3 % | 362.64 | (7.1 %) | 3.94 |
Q1 2017 | 393.53 | (6.6 %) | 180.47 | (16.7 %) | 109.97 | 5.5 % | 1.19 |
Q2 2017 | 351.28 | (14.3 %) | 138.63 | (34.8 %) | 61.95 | (16.4 %) | 0.67 |
Q3 2017 | 352.98 | (6.9 %) | 133.30 | (33.1 %) | 64.88 | (34.9 %) | 0.70 |
Q4 2017 | 364.60 | (10.0 %) | 145.47 | (27.2 %) | 82.69 | (2.4 %) | 0.90 |
2017 | 1,462.39 | (9.5 %) | 597.87 | (27.8 %) | 319.49 | (11.9 %) | 3.47 |
Q1 2018 | 395.11 | 0.4 % | 160.42 | (11.1 %) | 87.13 | (20.8 %) | 0.95 |
Q2 2018 | 346.13 | (1.5 %) | 116.91 | (15.7 %) | 34.27 | (44.7 %) | 0.37 |
Q3 2018 | 338.77 | (4.0 %) | 111.87 | (16.1 %) | 20.16 | (68.9 %) | 0.22 |
Q4 2018 | 310.68 | (14.8 %) | 111.56 | (23.3 %) | 30.69 | (62.9 %) | 0.33 |
2018 | 1,390.69 | (4.9 %) | 500.75 | (16.2 %) | 172.25 | (46.1 %) | 1.87 |
Q1 2019 | 350.18 | (11.4 %) | 101.63 | (36.6 %) | 14.59 | (83.3 %) | 0.16 |
Q2 2019 | 353.20 | 2.0 % | 102.76 | (12.1 %) | 12.28 | (64.2 %) | 0.13 |
Q3 2019 | 386.76 | 14.2 % | 119.96 | 7.2 % | 33.23 | 64.8 % | 0.36 |
Q4 2019 | 406.51 | 30.8 % | 148.59 | 33.2 % | 37.47 | 22.1 % | 0.41 |
2019 | 1,496.65 | 7.6 % | 472.93 | (5.6 %) | 97.57 | (43.4 %) | 1.06 |
Q1 2020 | 436.31 | 24.6 % | 146.86 | 44.5 % | 21.18 | 45.2 % | 0.23 |
Q2 2020 | 373.26 | 5.7 % | 120.49 | 17.3 % | 16.35 | 33.2 % | 0.18 |
Q3 2020 | 492.13 | 27.2 % | 171.91 | 43.3 % | 34.91 | 5.1 % | 0.38 |
Q4 2020 | 448.89 | 10.4 % | 139.12 | (6.4 %) | 9.54 | (74.5 %) | 0.10 |
2020 | 1,750.59 | 17.0 % | 578.37 | 22.3 % | 81.99 | (16.0 %) | 0.89 |
Q1 2021 | 418.37 | (4.1 %) | 123.16 | (16.1 %) | 12.10 | (42.9 %) | 0.13 |
Q2 2021 | 456.57 | 22.3 % | 152.64 | 26.7 % | 9.14 | (44.1 %) | 0.10 |
Q3 2021 | 498.73 | 1.3 % | 172.27 | 0.2 % | 14.35 | (58.9 %) | 0.16 |
Q4 2021 | 498.95 | 11.2 % | 160.11 | 15.1 % | (18.39) | (292.8 %) | (0.20) |
2021 | 1,872.62 | 7.0 % | 608.18 | 5.2 % | 17.20 | (79.0 %) | 0.19 |
Q1 2022 | 513.32 | 22.7 % | 165.02 | 34.0 % | 20.49 | 69.3 % | 0.22 |
Q2 2022 | 508.09 | 11.3 % | 158.77 | 4.0 % | 10.43 | 14.1 % | 0.11 |
Q3 2022 | 512.37 | 2.7 % | 152.21 | (11.6 %) | 11.11 | (22.6 %) | 0.12 |
Q4 2022 | 617.96 | 23.9 % | 204.01 | 27.4 % | 33.16 | 280.3 % | 0.36 |
2022 | 2,151.74 | 14.9 % | 680.01 | 11.8 % | 75.18 | 337.1 % | 0.82 |
Q1 2023 | 637.99 | 24.3 % | 225.50 | 36.6 % | 50.12 | 144.6 % | 0.54 |
Q2 2023 | 624.33 | 22.9 % | 228.63 | 44.0 % | 40.25 | 286.0 % | 0.44 |
Q3 2023 | 671.05 | 31.0 % | 266.33 | 75.0 % | 53.30 | 379.9 % | 0.58 |
Q4 2023 | 719.81 | 16.5 % | 293.96 | 44.1 % | 36.50 | 10.1 % | 0.40 |
2023 | 2,653.17 | 23.3 % | 1,014.41 | 49.2 % | 180.18 | 139.7 % | 1.96 |
Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
---|---|---|---|---|---|---|---|
2014 | 1,398.75 | 68.9 % | 749.76 | 74.2 % | 331.97 | 142.0 % | 3.61 |
2015 | 1,534.53 | 9.7 % | 810.13 | 8.1 % | 390.25 | 17.6 % | 4.24 |
2016 | 1,615.64 | 5.3 % | 828.39 | 2.3 % | 362.64 | (7.1 %) | 3.94 |
2017 | 1,462.39 | (9.5 %) | 597.87 | (27.8 %) | 319.49 | (11.9 %) | 3.47 |
2018 | 1,390.69 | (4.9 %) | 500.75 | (16.2 %) | 172.25 | (46.1 %) | 1.87 |
2019 | 1,496.65 | 7.6 % | 472.93 | (5.6 %) | 97.57 | (43.4 %) | 1.06 |
2020 | 1,750.59 | 17.0 % | 578.37 | 22.3 % | 81.99 | (16.0 %) | 0.89 |
2021 | 1,872.62 | 7.0 % | 608.18 | 5.2 % | 17.20 | (79.0 %) | 0.19 |
2022 | 2,151.74 | 14.9 % | 680.01 | 11.8 % | 75.18 | 337.1 % | 0.82 |
2023 | 2,653.17 | 23.3 % | 1,014.41 | 49.2 % | 180.18 | 139.7 % | 1.96 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2014 | - | - | - |
Q2 2014 | - | - | - |
Q3 2014 | - | - | - |
Q4 2014 | 53.60 % | 25.57 % | 23.73 % |
2014 | 53.60 % | 25.57 % | 23.73 % |
Q1 2015 | 53.05 % | 27.10 % | 24.96 % |
Q2 2015 | 53.39 % | 26.84 % | 24.46 % |
Q3 2015 | 52.93 % | 27.56 % | 25.09 % |
Q4 2015 | 52.79 % | 28.05 % | 25.43 % |
2015 | 52.79 % | 28.05 % | 25.43 % |
Q1 2016 | 52.27 % | 27.77 % | 24.87 % |
Q2 2016 | 51.57 % | 26.50 % | 23.17 % |
Q3 2016 | 51.71 % | 26.41 % | 23.34 % |
Q4 2016 | 51.27 % | 26.12 % | 22.45 % |
2016 | 51.27 % | 26.12 % | 22.45 % |
Q1 2017 | 49.90 % | 26.91 % | 23.20 % |
Q2 2017 | 46.99 % | 27.02 % | 23.30 % |
Q3 2017 | 43.41 % | 25.39 % | 21.40 % |
Q4 2017 | 40.88 % | 25.40 % | 21.85 % |
2017 | 40.88 % | 25.40 % | 21.85 % |
Q1 2018 | 39.47 % | 24.17 % | 20.26 % |
Q2 2018 | 38.12 % | 22.54 % | 18.44 % |
Q3 2018 | 37.01 % | 20.57 % | 15.52 % |
Q4 2018 | 36.01 % | 18.10 % | 12.39 % |
2018 | 36.01 % | 18.10 % | 12.39 % |
Q1 2019 | 32.84 % | 13.74 % | 7.41 % |
Q2 2019 | 31.62 % | 12.25 % | 5.74 % |
Q3 2019 | 31.12 % | 12.85 % | 6.48 % |
Q4 2019 | 31.60 % | 13.48 % | 7.05 % |
2019 | 31.60 % | 13.48 % | 7.05 % |
Q1 2020 | 32.74 % | 13.41 % | 7.09 % |
Q2 2020 | 33.43 % | 14.66 % | 7.25 % |
Q3 2020 | 34.41 % | 14.80 % | 6.90 % |
Q4 2020 | 33.04 % | 13.40 % | 4.68 % |
2020 | 33.04 % | 13.40 % | 4.68 % |
Q1 2021 | 32.01 % | 12.65 % | 3.20 % |
Q2 2021 | 32.32 % | 11.91 % | 2.68 % |
Q3 2021 | 32.22 % | 11.12 % | 1.77 % |
Q4 2021 | 32.48 % | 9.71 % | 0.18 % |
2021 | 32.48 % | 9.71 % | 0.18 % |
Q1 2022 | 33.04 % | 10.93 % | 1.49 % |
Q2 2022 | 32.50 % | 10.71 % | 1.50 % |
Q3 2022 | 31.29 % | 10.75 % | 1.12 % |
Q4 2022 | 31.60 % | 13.35 % | 3.49 % |
2022 | 31.60 % | 13.31 % | 3.49 % |
Q1 2023 | 32.53 % | 15.00 % | 4.60 % |
Q2 2023 | 33.87 % | 16.89 % | 5.63 % |
Q3 2023 | 36.23 % | 19.39 % | 6.93 % |
Q4 2023 | 38.23 % | 20.06 % | 6.79 % |
2023 | 38.23 % | 20.06 % | 6.79 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2014 | 53.60 % | 25.57 % | 23.73 % |
2015 | 52.79 % | 28.05 % | 25.43 % |
2016 | 51.27 % | 26.12 % | 22.45 % |
2017 | 40.88 % | 25.40 % | 21.85 % |
2018 | 36.01 % | 18.10 % | 12.39 % |
2019 | 31.60 % | 13.48 % | 7.05 % |
2020 | 33.04 % | 13.40 % | 4.68 % |
2021 | 32.48 % | 9.71 % | 0.18 % |
2022 | 31.60 % | 13.31 % | 3.49 % |
2023 | 38.23 % | 20.06 % | 6.79 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2014 | 55.54 % | 23.76 % | 22.32 % |
Q2 2014 | 53.53 % | 28.54 % | 26.74 % |
Q3 2014 | 54.00 % | 25.72 % | 23.01 % |
Q4 2014 | 51.45 % | 24.43 % | 22.92 % |
Q1 2015 | 53.36 % | 29.47 % | 26.91 % |
Q2 2015 | 54.81 % | 27.44 % | 24.67 % |
Q3 2015 | 52.02 % | 28.83 % | 25.77 % |
Q4 2015 | 51.12 % | 26.62 % | 24.44 % |
Q1 2016 | 51.39 % | 28.30 % | 24.72 % |
Q2 2016 | 51.82 % | 22.50 % | 18.06 % |
Q3 2016 | 52.60 % | 28.28 % | 26.29 % |
Q4 2016 | 49.36 % | 25.48 % | 20.92 % |
Q1 2017 | 45.86 % | 31.64 % | 27.94 % |
Q2 2017 | 39.46 % | 22.25 % | 17.64 % |
Q3 2017 | 37.76 % | 21.46 % | 18.38 % |
Q4 2017 | 39.90 % | 25.53 % | 22.68 % |
Q1 2018 | 40.60 % | 27.04 % | 22.05 % |
Q2 2018 | 33.78 % | 15.35 % | 9.90 % |
Q3 2018 | 33.02 % | 13.01 % | 5.95 % |
Q4 2018 | 35.91 % | 15.33 % | 9.88 % |
Q1 2019 | 29.02 % | 11.44 % | 4.17 % |
Q2 2019 | 29.09 % | 9.62 % | 3.48 % |
Q3 2019 | 31.02 % | 15.07 % | 8.59 % |
Q4 2019 | 36.55 % | 17.05 % | 11.18 % |
Q1 2020 | 33.66 % | 11.59 % | 4.85 % |
Q2 2020 | 32.28 % | 15.23 % | 4.38 % |
Q3 2020 | 34.93 % | 15.45 % | 7.09 % |
Q4 2020 | 30.99 % | 11.40 % | 2.13 % |
Q1 2021 | 29.44 % | 8.41 % | (1.30 %) |
Q2 2021 | 33.43 % | 11.79 % | 2.11 % |
Q3 2021 | 34.54 % | 12.53 % | 3.71 % |
Q4 2021 | 32.09 % | 6.10 % | (3.86 %) |
Q1 2022 | 32.15 % | 13.30 % | 3.99 % |
Q2 2022 | 31.25 % | 10.84 % | 2.05 % |
Q3 2022 | 29.71 % | 12.63 % | 2.17 % |
Q4 2022 | 33.01 % | 16.05 % | 5.37 % |
Q1 2023 | 35.34 % | 19.20 % | 7.86 % |
Q2 2023 | 36.62 % | 18.87 % | 6.45 % |
Q3 2023 | 39.69 % | 23.14 % | 7.94 % |
Q4 2023 | 40.84 % | 19.00 % | 5.07 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2014 | 92.04 | - | - | 10.70 |
Q2 2014 | 92.04 | - | - | 11.69 |
Q3 2014 | 92.04 | - | - | 12.48 |
Q4 2014 | 92.04 | 3.61 | 3.61 | 12.38 |
Q1 2015 | 92.04 | 3.88 | 3.88 | 13.50 |
Q2 2015 | 92.04 | 3.87 | 3.87 | 12.67 |
Q3 2015 | 92.04 | 4.05 | 4.05 | 13.63 |
Q4 2015 | 92.04 | 4.24 | 4.24 | 14.70 |
Q1 2016 | 92.04 | 4.23 | 4.23 | 16.39 |
Q2 2016 | 92.04 | 4.03 | 4.03 | 15.20 |
Q3 2016 | 92.04 | 4.13 | 4.13 | 16.43 |
Q4 2016 | 92.04 | 3.94 | 3.94 | 17.32 |
Q1 2017 | 92.04 | 4.00 | 4.00 | 18.46 |
Q2 2017 | 92.04 | 3.87 | 3.87 | 17.09 |
Q3 2017 | 92.04 | 3.49 | 3.49 | 17.74 |
Q4 2017 | 92.04 | 3.47 | 3.47 | 15.75 |
Q1 2018 | 92.04 | 3.22 | 3.22 | 16.69 |
Q2 2018 | 92.04 | 2.92 | 2.92 | 15.07 |
Q3 2018 | 92.04 | 2.44 | 2.44 | 15.29 |
Q4 2018 | 92.04 | 1.87 | 1.87 | 15.71 |
Q1 2019 | 92.04 | 1.08 | 1.08 | 15.87 |
Q2 2019 | 92.04 | 0.84 | 0.84 | 16.00 |
Q3 2019 | 92.04 | 0.99 | 0.99 | 16.36 |
Q4 2019 | 92.04 | 1.06 | 1.15 | 16.54 |
Q1 2020 | 92.04 | 1.13 | 1.22 | 16.77 |
Q2 2020 | 92.04 | 1.18 | 1.26 | 16.95 |
Q3 2020 | 92.04 | 1.19 | 1.28 | 17.33 |
Q4 2020 | 92.04 | 0.89 | 0.89 | 13.38 |
Q1 2021 | 92.04 | 0.79 | 0.60 | 13.51 |
Q2 2021 | 92.04 | 0.71 | 0.53 | 13.61 |
Q3 2021 | 92.04 | 0.49 | 0.35 | 13.77 |
Q4 2021 | 92.04 | 0.19 | 0.04 | 13.66 |
Q1 2022 | 92.04 | 0.28 | 0.32 | 13.89 |
Q2 2022 | 92.04 | 0.29 | 0.33 | 13.92 |
Q3 2022 | 92.04 | 0.26 | 0.25 | 14.04 |
Q4 2022 | 92.04 | 0.82 | 0.82 | 14.83 |
Q1 2023 | 92.04 | 1.14 | 1.14 | 15.37 |
Q2 2023 | 92.04 | 1.46 | 1.46 | 15.82 |
Q3 2023 | 92.04 | 1.92 | 1.92 | 16.41 |
Q4 2023 | 92.04 | 1.96 | 1.96 | 16.50 |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2014 | 92.04 | 3.61 | 3.61 | 12.38 |
2015 | 92.04 | 4.24 | 4.24 | 14.70 |
2016 | 92.04 | 3.94 | 3.94 | 17.32 |
2017 | 92.04 | 3.47 | 3.47 | 15.75 |
2018 | 92.04 | 1.87 | 1.87 | 15.71 |
2019 | 92.04 | 1.06 | 1.15 | 16.54 |
2020 | 92.04 | 0.89 | 0.89 | 13.38 |
2021 | 92.04 | 0.19 | 0.04 | 13.66 |
2022 | 92.04 | 0.82 | 0.82 | 14.83 |
2023 | 92.04 | 1.96 | 1.96 | 16.50 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2014 | - | - | - |
Q2 2014 | - | - | - |
Q3 2014 | - | - | - |
Q4 2014 | - | - | - |
Q1 2015 | - | - | - |
Q2 2015 | - | - | - |
Q3 2015 | - | - | - |
Q4 2015 | - | - | - |
Q1 2016 | 17.17 | 17.17 | 4.43 |
Q2 2016 | 17.16 | 17.16 | 4.56 |
Q3 2016 | 12.41 | 12.41 | 3.12 |
Q4 2016 | 18.62 | 18.62 | 4.23 |
Q1 2017 | 18.48 | 18.48 | 4.01 |
Q2 2017 | 19.45 | 19.45 | 4.41 |
Q3 2017 | 17.98 | 17.98 | 3.54 |
Q4 2017 | 15.52 | 15.52 | 3.42 |
Q1 2018 | 17.90 | 17.90 | 3.46 |
Q2 2018 | 20.02 | 20.02 | 3.88 |
Q3 2018 | 15.00 | 15.00 | 2.39 |
Q4 2018 | 17.34 | 17.34 | 2.07 |
Q1 2019 | 29.49 | 29.49 | 2.01 |
Q2 2019 | 32.63 | 32.63 | 1.72 |
Q3 2019 | 26.36 | 26.36 | 1.59 |
Q4 2019 | 28.02 | 25.89 | 1.80 |
Q1 2020 | 22.49 | 20.89 | 1.52 |
Q2 2020 | 25.77 | 23.99 | 1.79 |
Q3 2020 | 30.69 | 28.61 | 2.11 |
Q4 2020 | 39.35 | 39.35 | 2.62 |
Q1 2021 | 44.44 | More than 50 | 2.60 |
Q2 2021 | More than 50 | More than 50 | 2.88 |
Q3 2021 | More than 50 | More than 50 | 2.75 |
Q4 2021 | More than 50 | More than 50 | 2.32 |
Q1 2022 | More than 50 | More than 50 | 2.34 |
Q2 2022 | More than 50 | More than 50 | 2.31 |
Q3 2022 | More than 50 | More than 50 | 1.94 |
Q4 2022 | 31.16 | 31.16 | 1.72 |
Q1 2023 | 33.06 | 33.06 | 2.45 |
Q2 2023 | 48.33 | 48.33 | 4.47 |
Q3 2023 | 28.68 | 28.68 | 3.36 |
Q4 2023 | 45.11 | 45.11 | 5.35 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2014 | - | - | - |
2015 | - | - | - |
2016 | 18.62 | 18.62 | 4.23 |
2017 | 15.52 | 15.52 | 3.42 |
2018 | 17.34 | 17.34 | 2.07 |
2019 | 28.02 | 25.89 | 1.80 |
2020 | 39.34 | 39.34 | 2.62 |
2021 | More than 50 | More than 50 | 2.32 |
2022 | 31.16 | 31.16 | 1.72 |
2023 | 45.11 | 45.11 | 5.35 |
Q4 2023
2023
Period | Inpatient clinics | Outpatient clinics | Pharmacy Sales | Others |
---|---|---|---|---|
Q1 2014 | 207.07 | 85.01 | 64.94 | 2.16 |
Q2 2014 | 200.50 | 77.40 | 66.66 | 2.51 |
Q1 2015 | 224.99 | 91.95 | 70.24 | 4.46 |
Q2 2015 | 211.41 | 86.64 | 70.30 | 3.65 |
Q3 2015 | 200.38 | 85.53 | 63.54 | 2.76 |
Q4 2015 | 220.47 | 119.55 | 72.94 | 5.72 |
Q1 2016 | 241.22 | 100.20 | 73.04 | 7.06 |
Q2 2016 | 229.99 | 99.85 | 72.93 | 7.31 |
Q3 2016 | 224.32 | 89.88 | 62.16 | 2.72 |
Q4 2016 | 220.91 | 107.73 | 72.64 | 3.69 |
Q1 2017 | 242.80 | 104.89 | 71.94 | 4.27 |
Q2 2017 | 224.48 | 92.89 | 70.77 | 3.54 |
Q3 2017 | 133.39 | 85.39 | 60.16 | 3.27 |
Q4 2017 | 172.44 | 114.51 | 71.35 | 6.30 |
Q1 2018 | 214.32 | 109.10 | 68.50 | 3.20 |
Q2 2018 | 188.62 | 79.63 | 76.10 | 1.78 |
Q3 2018 | 184.16 | 98.93 | 53.64 | 2.04 |
Q4 2018 | 147.36 | 97.71 | 61.91 | 3.70 |
Q1 2019 | 181.07 | 97.28 | 67.29 | 4.54 |
Q2 2019 | 185.66 | 95.13 | 68.96 | 3.44 |
Q3 2019 | 223.51 | 95.92 | 64.81 | 2.51 |
Q4 2019 | 222.02 | 111.18 | 69.80 | 3.51 |
Q1 2020 | 264.27 | 98.09 | 71.34 | 2.60 |
Q2 2020 | 238.16 | 70.59 | 61.71 | 2.81 |
Q3 2020 | 301.73 | 111.20 | 76.35 | 2.85 |
Q4 2020 | 281.15 | 110.99 | 74.56 | 3.81 |
Q1 2021 | 236.94 | 115.00 | 61.88 | 4.54 |
Q2 2021 | 284.69 | 102.17 | 67.31 | 2.40 |
Q3 2021 | 292.19 | 139.00 | 61.71 | 5.83 |
Q4 2021 | 284.48 | 135.06 | 74.52 | 4.89 |
Q1 2022 | 290.29 | 141.03 | 78.90 | 3.10 |
Q2 2022 | 294.67 | 138.11 | 73.11 | 2.20 |
Q3 2022 | 293.31 | 145.39 | 71.94 | 1.74 |
Q4 2022 | 360.72 | 163.35 | 89.59 | 4.30 |
Q1 2023 | 369.08 | 176.60 | 90.42 | 1.88 |
Q2 2023 | 366.84 | 172.86 | 76.94 | 7.70 |
Q3 2023 | 404.17 | 180.18 | 89.81 | - |
Q4 2023 | 405.24 | 210.55 | 103.89 | 0.13 |
Period | Inpatient clinics | Outpatient clinics | Pharmacy Sales | Others |
---|---|---|---|---|
2014 | 807.92 | 323.31 | 257.32 | 10.20 |
2015 | 857.25 | 383.67 | 277.02 | 16.59 |
2016 | 916.44 | 397.66 | 280.76 | 20.77 |
2017 | 773.12 | 397.68 | 274.21 | 17.38 |
2018 | 734.45 | 385.37 | 260.14 | 10.73 |
2019 | 812.27 | 399.51 | 270.86 | 14.01 |
2020 | 1,085.30 | 390.88 | 283.96 | 12.07 |
2021 | 1,098.30 | 491.24 | 265.42 | 17.66 |
2022 | 1,238.98 | 587.88 | 313.54 | 11.34 |
2023 | 1,545.33 | 740.19 | 361.06 | 6.59 |
Item | Q4 2023 (e) | Q4 2023 (a) | Change |
---|---|---|---|
Average | 53.69 | 36.50 | (32.0 %) |
Item | Q4 2023 (e) | Q4 2023 (a) | Change |
---|---|---|---|
Hermes | 46.00 | 36.50 | (20.6) % |
United Securities Company | 30.00 | 36.50 | 21.7 % |
AlJazira Capital | 56.50 | 36.50 | (35.4) % |
Al Rajhi Capital | 58.00 | 36.50 | (37.1) % |
OSOOL AND BAKHEET | 65.44 | 36.50 | (44.2) % |
SNB Capital | 66.20 | 36.50 | (44.9) % |
Current | |
Market Cap (M Riyal) | 7,363.20 |
Enterprise Value (EV) (M) | 9,698.77 |
Shares Outstanding ((M)) | 92.04 |
EPS ( Riyal) (TTM) | 1.98 |
Book Value (BV) ( Riyal) | 17.08 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | 40.46 |
P/E (TTM) | 40.46 |
Price/book | 4.68 |
Return on Average Assets (%) (TTM) | 3.8 |
Return on Average Equity (%) (TTM) | 12.2 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}